Executive pay
Ultragenyx Pharmaceutical (RARE) executive compensation
What Ultragenyx Pharmaceutical Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2026 proxy statement
Emil D. Kakkis, M.D., Ph.D. paid $11.4M (-17% on the year), pay ratio 38:1.
Filed Mar 27, 2026